Trial Profile
Prospective, randomized, open-label, clinical trial comparing the effects of topiroxostat and febuxostat on serum uric acid, endothelial function and markers for kidney injury
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Apr 2017
Price :
$35
*
At a glance
- Drugs Febuxostat (Primary) ; Topiroxostat (Primary)
- Indications Hyperuricaemia
- Focus Therapeutic Use
- 03 Apr 2017 New trial record